# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Needham analyst David Saxon reiterates Staar Surgical (NASDAQ:STAA) with a Hold.
Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $46 ...
Piper Sandler analyst Matt O'Brien maintains Staar Surgical (NASDAQ:STAA) with a Neutral and raises the price target fro...
Mizuho analyst Anthony Petrone maintains Staar Surgical (NASDAQ:STAA) with a Buy and raises the price target from $53 to $55.
Agreement is Largest Commitment to EVO ICL™ in the U.S.STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer ...
Staar Surgical (NASDAQ:STAA) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.11...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...